Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Guilmette

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Bioinorganic Chemistry|January 1, 1976
Biological effects of the enhanced excretion of zinc after calcium diethylenetriaminepentaacetate chelation therapyN Cohen, R Guilmette
Radiation Protection Dosimetry|October 7, 2003
The application of Bayesian techniques in the interpretation of bioassay dataG Miller, T Little, R Guilmette
Radiation Protection Dosimetry|July 29, 2008
IMPDOS (improved dosimetry and risk assessment for plutonium-induced diseases): internal dosimetry software tools developed for the Mayak worker studyG Miller, L Bertelli, R Guilmette
Radiation Protection Dosimetry|October 7, 2003
Internal dosimetry of uranium isotopes using Bayesian inference methodsT T Little, G Miller, R Guilmette
Radiation Protection Dosimetry|April 3, 2002
Bayesian internal dosimetry calculations using Markov Chain Monte CarloG Miller, H F Martz, T T Little, et al.
Radiation Protection Dosimetry|October 11, 2003
Efficacy of 3,4,3-LI(1,2-HOPO) for decorporation of Pu, Am and U from rats injected intramuscularly with high-fired particles of MOXF Paquet, V Chazel, P Houpert, et al.
Radiation Protection Dosimetry|April 1, 2008
A study of early Los Alamos internal exposures to plutoniumG Miller, L Bertelli, R Guilmette, et al.
Health Physics|March 28, 2014
Efficacy of Prussian blue on 137Cs decorporation therapyD R Melo, J L Lipsztein, R Leggett, et al.
Radiation Protection Dosimetry|March 6, 2007
Worldwide bioassay data resources for plutonium/americium internal dosimetry studiesG Miller, A E Riddell, R Filipy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1995
A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complexW L Fodor, S A Rollins, E R Guilmette, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Bioinorganic Chemistry|January 1, 1976
Biological effects of the enhanced excretion of zinc after calcium diethylenetriaminepentaacetate chelation therapyN Cohen, R Guilmette
Radiation Protection Dosimetry|October 7, 2003
The application of Bayesian techniques in the interpretation of bioassay dataG Miller, T Little, R Guilmette
Radiation Protection Dosimetry|July 29, 2008
IMPDOS (improved dosimetry and risk assessment for plutonium-induced diseases): internal dosimetry software tools developed for the Mayak worker studyG Miller, L Bertelli, R Guilmette
Radiation Protection Dosimetry|October 7, 2003
Internal dosimetry of uranium isotopes using Bayesian inference methodsT T Little, G Miller, R Guilmette
Radiation Protection Dosimetry|April 3, 2002
Bayesian internal dosimetry calculations using Markov Chain Monte CarloG Miller, H F Martz, T T Little, et al.
Radiation Protection Dosimetry|October 11, 2003
Efficacy of 3,4,3-LI(1,2-HOPO) for decorporation of Pu, Am and U from rats injected intramuscularly with high-fired particles of MOXF Paquet, V Chazel, P Houpert, et al.
Radiation Protection Dosimetry|April 1, 2008
A study of early Los Alamos internal exposures to plutoniumG Miller, L Bertelli, R Guilmette, et al.
Health Physics|March 28, 2014
Efficacy of Prussian blue on 137Cs decorporation therapyD R Melo, J L Lipsztein, R Leggett, et al.
Radiation Protection Dosimetry|March 6, 2007
Worldwide bioassay data resources for plutonium/americium internal dosimetry studiesG Miller, A E Riddell, R Filipy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1995
A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complexW L Fodor, S A Rollins, E R Guilmette, et al.
Pageof 2